PAR:BLC

Bastide Le Confort Médical S.A. · PAR · Healthcare · EUR · FY for 2026

Figures on this page computed 2026-11-08 12:25 UTC

Last close

n/aEUR

Market data

2.5xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
EUR
- computed
- Computed from the filing for 2026
7.9%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
12.0%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2026
- Computed from the filing for 2026
6.4%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2026
- Computed from the filing for 2026
2.28Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.4%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
EUR
- computed

Safety is the furthest below its sector's middle: 0.27 against 0.57 on the market's range.

All from 100

lens 2 of 9

Sales

221

2017-06-30 to 2026-06-30100 at the start221

Sales: 100.00 on 2017-06-30 to 221.17 on 2026-06-30, up 121%.

Profit

1,071

2017-06-30 to 2026-06-30100 at the start1,071

Profit: 100.00 on 2017-06-30 to 1070.93 on 2026-06-30, up 971%.

Shares in issue

100

2017-06-30 to 2026-06-30100 at the start100

Shares in issue: 100.00 on 2017-06-30 to 100.46 on 2026-06-30, up 0%.

Sales is at 221, Profit is at 1071, Shares in issue is at 100, against 100 in 2017.

Sales is at 221, Profit is at 1071, Shares in issue is at 100, against 100 in 2017.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2026

Sales, where the first year is 100221
Source
computed
Statement
income
Fiscal year
2026
Reported in
EUR
Profit, where the first year is 1001,071
Source
computed
Statement
income
Fiscal year
2026
Reported in
EUR
Shares in issue, where the first year is 100101
Source
computed
Statement
income
Fiscal year
2026
Reported in
EUR